QA: Catalyst Pharmaceuticals INC in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001369568_2020_Catalyst_Pharmaceuticals_INC.pdf

Logs

Graph

Absolute values for 0001369568, Catalyst Pharmaceuticals INC

  xvar xval
0 AssetsCurrent 111,363,623
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 210,467
3 remainder_Assets 802,140
4 LiabilitiesCurrent 24,098,742
5 LiabilitiesNoncurrent 647,532
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 14,759,139
8 SellingGeneralAndAdministrativeExpense 45,450,032
9 ResearchAndDevelopmentExpense 18,872,568
10 remainder_Expenses 1,311,850
11 remainder_Revenues 490,714
12 remainder_NetIncome 607,280,195
13 remainder_ComprehensiveNetIncome -20,247
  yvar yval
0 Assets 112,376,230
1 Liabilities 24,746,274
2 Expenses 80,393,589
3 Revenues 490,714
4 StockholdersEquity 87,629,956
5 NetIncome 527,377,320
6 ComprehensiveNetIncome 527,367,196
7 BaseVar 412,653,624
8 EconomicCapitalRatiobeforeLimitedLiability 10.5
9 EconomicCapitalRatio 10.5

Edgar->Model Mapping

Feature Distribution

Change over Time